Skip to main content

Table 1 Clinical characteristics of the patients with cirrhosis and cirrhosis plus HCC

From: AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

 

Cirrhosis

HCC

Number

41

50

Age (years)

54.3 ± 9.62

67.5 ± 12.02

Male:Female

28:13

40:10

ALD:NAFLD

33:08

30:20

Childs-Pugh A:B:C

22:14:05

27:18:05

Portal vein invasion

NA

8

Single nodule

NA

22

Two nodules

NA

10

≥ 3 nodules

NA

18

  1. The difference in age between HCC and cirrhosis alone patients was statistically significant (p < 0.001; Pearson Chi square test), while there was no significant difference between sex or Child-Pugh Stage in the two groups. NA – not applicable.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us